TY - JOUR
T1 - Daily physical activity and symptom reporting in breast cancer patients undergoing chemotherapy
T2 - An intensive longitudinal examination
AU - Phillips, Siobhan M.
AU - Welch, Whitney A.
AU - Fanning, Jason
AU - Santa-Maria, Cesar A.
AU - Gavin, Kara L.
AU - Auster-Gussman, Lisa A.
AU - Solk, Payton
AU - Lu, Marilyn
AU - Cullather, Erin
AU - Khan, Seema A.
AU - Kulkarni, Swati A.
AU - Gradishar, William
AU - Siddique, Juned
N1 - Funding Information:
S.M. Phillips reports grants from NCI and Lynn Sage Cancer Research Foundation during the conduct of the study. C.A. Santa-Maria reports grants from Pfizer, AstraZeneca, and Tesaro/GlaxoSmithKline outside the submitted work. No potential conflicts of interest were disclosed by the other authors.
Funding Information:
This study was supported by the Northwestern Memorial Hospital Lynn Sage Cancer Research Foundation Grants Initiative and the NCI K07CA196840 awarded to S. Phillips. L.A. Auster-Gussman was supported by T32CA193193.
Publisher Copyright:
© 2020 American Association for Cancer Research.
PY - 2020/12
Y1 - 2020/12
N2 - Background: Increased activity is beneficial during chemotherapy, but treatment-related symptoms may be a barrier. This study examines the relationship between daily fluctuations in symptoms and activity during chemotherapy. Methods: Women undergoing chemotherapy for breast cancer [n = 67;Mage = 48.6 (SD = 10.3)] wore an accelerometer 24 hours/ day and received four text prompts/day to rate symptoms for 10 consecutive days at the beginning, middle, and end of chemotherapy. Mixed-effects models were used to examine the between and within-person relationships between symptom ratings on a given day and moderate to vigorous physical activity (MVPA) and light physical activity (LPA) on that day and the following day controlling for relevant covariates and using the Bonferroni correction for multiple comparisons. Results: For MVPA and LPA, within-person associations were statistically significant for same day affect, fatigue, pain, walking, activities of daily living (ADL) physical function, and cognitive function. Previous day anxiety was associated with next day LPA. Every one point worse symptom rating than an individual's overall average was associated with: (i) between 1.49 (pain) and 4.94 (fatigue) minutes less MVPA and between 4.48 (pain) and 24.72 (ADL physical function) minutes less LPA that day, and (ii) 11.28 minutes less LPA the next day. No between-person effects were significant for MVPA or LPA. Conclusions: Daily within-person variations in symptoms were associated with MVPA and LPA during chemotherapy for breast cancer. Impact: Future work should explore relationships between symptoms and activity further and identify whether tailoring to symptoms enhances efficacy of physical activity promotion interventions during chemotherapy.
AB - Background: Increased activity is beneficial during chemotherapy, but treatment-related symptoms may be a barrier. This study examines the relationship between daily fluctuations in symptoms and activity during chemotherapy. Methods: Women undergoing chemotherapy for breast cancer [n = 67;Mage = 48.6 (SD = 10.3)] wore an accelerometer 24 hours/ day and received four text prompts/day to rate symptoms for 10 consecutive days at the beginning, middle, and end of chemotherapy. Mixed-effects models were used to examine the between and within-person relationships between symptom ratings on a given day and moderate to vigorous physical activity (MVPA) and light physical activity (LPA) on that day and the following day controlling for relevant covariates and using the Bonferroni correction for multiple comparisons. Results: For MVPA and LPA, within-person associations were statistically significant for same day affect, fatigue, pain, walking, activities of daily living (ADL) physical function, and cognitive function. Previous day anxiety was associated with next day LPA. Every one point worse symptom rating than an individual's overall average was associated with: (i) between 1.49 (pain) and 4.94 (fatigue) minutes less MVPA and between 4.48 (pain) and 24.72 (ADL physical function) minutes less LPA that day, and (ii) 11.28 minutes less LPA the next day. No between-person effects were significant for MVPA or LPA. Conclusions: Daily within-person variations in symptoms were associated with MVPA and LPA during chemotherapy for breast cancer. Impact: Future work should explore relationships between symptoms and activity further and identify whether tailoring to symptoms enhances efficacy of physical activity promotion interventions during chemotherapy.
UR - http://www.scopus.com/inward/record.url?scp=85100991034&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85100991034&partnerID=8YFLogxK
U2 - 10.1158/1055-9965.EPI-20-0659
DO - 10.1158/1055-9965.EPI-20-0659
M3 - Article
C2 - 32994340
AN - SCOPUS:85100991034
SN - 1055-9965
VL - 29
SP - 2608
EP - 2616
JO - Cancer Epidemiology Biomarkers and Prevention
JF - Cancer Epidemiology Biomarkers and Prevention
IS - 12
ER -